Skip to main content
Terumo Interventional Systems
 Terumo Group
Contact us
English
Español

  

  • Products

      Products

    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Procedures
      • Access
      • TLA - Therapeutic Lesion Access
      • Imaging
      • Therapeutic
      • Closure
    • Categories
    • All Products
  • Featured Topics

      Featured Topics

    • Radial First
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Ultimaster
    • TLA - Therapeutic Lesion Access
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us

      About Us

    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
    • Our Brand Story
  • News & Events

      News & Events

    • News
    • Events
 Terumo Group
Contact us
English
Español

  

  1. Home
  2. Featured Topics
  3. Radial First
  4. TRI - Transradial Intervention
  5. TRI 30th
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
Disclaimer
Please be aware that this website is developed, controlled, and operated as an educational and informational site for Healthcare Professionals and in no event directed to the general public. Also please be aware that a reference to a product or service on this website does not imply that such product or service is or will be available in your country or region of the world where it may be subject to different regulations and conditions of use. You should always rely on product information especially created for your country. If necessary, please contact your local Terumo affiliate to obtain the appropriate product information for your country.
Your use of this Website is governed by the “Terms of Use” and the “Privacy Policy”, and you are strongly advised to read the Terms of Use and the Privacy Policy carefully before any further use of the Website. If you cannot accept the Terms of Use and the Privacy Policy, please exit this Website.
Note: This Website is not intended to be reviewed by residents of following countries and areas. If you are a resident of any of these, please access the relevant website: United States, Canada, Europe, Middle East and Africa, LATAM, Australia and New Zealand, Thailand, Japan, and China.
Accept Decline
TRI 30th (image)
physician and sitting patient (image)

TRI 30th

For 30 years, we have been supporting the progress of transradial intervention (TRI) and remain fully committed to working with physicians and patients to improve quality of life further.
TRI 30th Anniversary

The year 2022 marks the 30th anniversary since Dr. F. Kiemeneij performed the first transradial intervention (August 1992).

In celebration of this milestone, Terumo Interventional Systems features the history of the transradial approach, which has evolved together with our customers. We continue to advance a radial first approach as our commitment to improving the quality of life of our patients.

Featured Contents
Newsletter (image)

TRI30th Newsletter Vol4

Download newsletter
Newsletter (image)

TRI30th Newsletter Vol3

Download newsletter
Distal Radial Access

Distal Radial Access

Go to website
Symposium & Events
Flyer (image)

30 Years of Transradial Access:Pushing the boundaries in cardiology & beyond

 

For 30 years, Terumo Interventional Systems has focused on bringing radial access to the forefront of clinical practice.Our radial access product portfolio, clinical research, and collaborative educational programs have helped thousands of healthcare providers transform coronary care. Looking to the future, we remain fully committed to improving patients‘ quality of life by expanding radial access as the first choice for interventional procedures.

Watch the symposium
TRI x TIS History
  •  
 

1992

First Trans-radial Intervension

First trans-radial angiography/intervention in cardiology

Transradial Intervention(image)

Dr. Campeau (Canada, 1989)   
Dr. Kiemeneij (The Netherlands, 1992)   
Dr. Wu (Taiwan, 1993)   
Dr. Saito (Japan, 1995)

2000

Product Launch

RADIFOCUS Introducer II M coat

RADIFOCUS Optitorque (image)

RADIFOCUS Optitorque   
TR Band

TR Band (image)

Trans-radial procedures

First trans-radial procedure in various fields

Neuro angioplasty (2000)   
Renal stent (2001)   
TACE (2002)   
Neuro coil (2004)   
Iliac stent (2005)

Expansion of Trans-radial procedures in the Europe Union

First PCR Live transmission by Dr. Saito   
Massy TRI Course (France)

Publication

1st clinical study on Radifocus™ Introducer II Mcoat™ & the benefits of hydrophilic coating on TRI   
Saito S. et al. Catheter Cardiovasc Interv 2002;56:328-32   
Usefulness of hydrophilic coating on arterial sheath introducer in transradial coronary intervention - Saito - 2002 - Catheterization and Cardiovascular Interventions - Wiley Online Library

Clinical study on Radifocus™ Introducer II Mcoat™ & its benefits on patient discomfort following TRI   
Kiemeneij F. et al. Catheter Cardiovasc Interv 2003;59:161-164   
Hydrophilic coating aids radial sheath withdrawal and reduces patient discomfort following transradial coronary intervention: A randomized double‐blind comparison of coated and uncoated sheaths - Kiemeneij - 2003 - Catheterization and Cardiovascular Interventions - Wiley Online Library

2005

Product Launch

HeartrailⅡ(image)

Heartrail II Guiding Catheter Ikari Curve   
1.5 mm J-TIP Radifocus™ Guide Wire M / Baby J

RADIFOCUS Guide Wire M (image)

1.5 mm J-TIP Radifocus™ Guide Wire M

Terumo Activity

China, Korea, Japan friendship TRI seminar was held

TRI seminar (image)

Brazil-Japan 100 years anniversary TRI seminar was held

Training Simulator (image) Training tools (image)

Training tools and simulators were developed

Presentation (image)

Trans-radial procedures

Expansion of trans-radial procedures in the United States, Asia, and Latin America

Publication

1st clinical study on Optitorque™'s universal shape TIGER II & its benefits for transradial angiography   
Kim S-M et al. Int J Cardiovasc Imaging 2006;22:295-303   
Novel diagnostic catheter specifically designed for both coronary arteries via the right transradial approach | SpringerLink

MORTAL Study demonstrates a reduction in mortality and transfusion rate with transradial access (PCI all-comers)   
Chase AJ et al. Heart 2008;94:1019–25   
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) | Heart (bmj.com)

2010

Product Launch

Glidesheath Slender (image)

Glidesheath Slender

Transradial Intervention (image)

Trans-radial procedures

Trans-radial intervention training for physicians in Latin America conducted through public-private partnership to contribute to improved patient quality of life and reduced healthcare expenditures.

ESC/EACTS 2014 guidelines: Class IIa A recommendation for patients with STEMI ACS -   
Kolh P et al. Eur J Cardiothorac Surg 2014;46:517–92

PCI consensus document recommends aiming for the highest possible transradial rate for optimal outcomes   
Rao S.V. et al. Catheter Cardiovasc Interv. 2014;83:228-36

Publication

1st clinical study on 6Fr Glidesheath Slender™ & its use for transradial coronary angiography and PCI   
Aminian A. et al. Catheter Cardiovasc Interv 2014;84:436-442

2015

Trans-radial procedures

ESC 2015 Guidelines: Class 1 A recommendation for patients with non-STEMI -   
Roffi M et al. Eur Heart J 2016;37:267–315.

ESC/EACTS 2018 Guidelines: Class 1 A recommendation for patients with STEMI ACS   
Ibanez B et al. Eur Heart J 2018;39:119–7

ESC/EACTS 2018 Guidelines: Class 1 A recommendation   
Neumann FJ et al. Eur Heart J 2019;40:87–16

Radial Access for Visceral Intervention (R.A.V.I)

Radial to Peripheral (R2P)

Distal radial approach

ESC 2019 guidelines: Class I B recommendation in elderly patients   
Knuuti J et al. Eur Heart J 2020;41:407–77

International Consensus Paper on Best Practices for the pr ion of radial artery occlusion   
Bernat I et al. J Am Coll Cardiol Interv 2019;12:2235–46.

Terumo Activity

Partnered with Euro PCR and conducted training.

Publication

The MATRIX Access trial demonstrates clinically relevant reduction in all-cause mortality with transradial access in patients with STEMI or non-STEMI ACS   
Valgimigli M et al. Lancet 2015;385:2465–76

1st clinical study on 5Fr Glidesheath Slender™ & its use for transradial coronary angiography and PCI   
Yoshimachi F. et al. Cardiovasc Interv and Ther 2016;31:38-41

RAP and BEAT trial compares 6Fr Glidesheath Slender™ with a standard 5 Fr sheath for transradial coronary angiography and PCI   
Aminian A. et al. EuroIntervention. 2017;13:e549-e556.

CRASOC I, II, and III studies featuring with TR Band™ demonstrates the benefits of a gentle and short hemostasis for transradial coronary angiography and PCI   
Dangoisse V. et al Am J Cardiol. 2017;120:374-379

1st clinical study on 7Fr Glidesheath Slender™ & its use for complex transradial PCI   
Aminian A. et al. Catheter Cardiovasc Interv 2017;89:1014-1020

RAP and BEAT trial substudy featuring with TR Band™ demonstrates the benefits of short hemostasis time on radial artery patency   
Aminian A. et al Catheter Cardiovasc Interv. 2018 ;92:844-851

Clinical trial on Optitorque™'s universal shape TIGER II & its benefits over conventional two-catheter strategy   
Xanthopoulou I et al. EuroIntervention 2018;13:1950-1958

Clinical study featuring Optitorque™'s universal shape TIGER I demonstrates a positive impact on coronary catheterization performance and economic costs   
Costa-Mateu J et al. Arq Bras Cardiol 2019;113:960-968

Clinical study featuring 7 Fr Glidesheath Slender™ supports its uses for left distal transradial approach & CTO intervention   
Gasparini G.L. et al. EuroIntervention. 2019;15:126-128

2020

Product Launch

RADIFOCUS Glidecath R.A.V.I. MG1/MG2 Shape

Trans-radial procedures

ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A   
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Journal of the American College of Cardiology (jacc.org)

Publication

COLOR Trial featuring 7Fr Glidesheath Slender™ demonstrates that TRA is superior to TFA in complex large bore PCI   
Meijers T.A. et al. JACC Cardiovasc Interv.2021;14:1293-1303

1st clinical study on Heartrail II's Ikari left curve & its benefits door-to-balloon time for PCI STEMI patients   
Lee K.H. et al. Catheter Cardiovasc Interv. 2021 May 31. Online ahead of print

DISCO RADIAL trial featuring Glidesheath Slender™ designed to investigate the benefits of dTRA over cTRA on RAO rates at discharge   
Terumo Press Release 21 January 2020. Available at: https://www.terumo.com/pressrelease/detail/20200121/514/; Glidesheath Slender™ product   
information https://www.terumois.com/products/access/glidesheath-slender.html; all accessed May 2020

pattern01.png

Newsletter

 

Newsletter (image)

TRI 30th Anniversary Newsletter

Radial approach topics are regularly available and include the history, clinical outcomes, benefits, dedicated devices, guidelines, and other topics.

Vol.4 Latest Evidence and Guidelines for Radial Access
Vol.3 30 Years of Transradial Access
Vol.2 Same-Day Discharge
Vol.1 TRI History
Product Information
Glidesheath Slender (image)
RADIFOCUS Guide Wire M (image)
RADIFOCUS Optitorque (image)
Heartrail II (image)
TR Band (image)
R.A.V.I.
Educational Contents

 

Sheath insertion (image)
Sheath Insertion
The use of a slender sheath is effective in reducing the risk of arterial spasms and radial occlusion. Glidesheath SlenderTM ensures smooth insertion and removal during the transradial procedures.1
Read more

 

Catheter (image)
Catheter Manipulation
This section provides instructions on how to manipulate the bilateral angiographic catheter to engage both coronary arteries efficiently. Tips are provided on ways to manage a complex anatomy.
Read more

 

Hemostasis (image)
Hemostasis
The TR Band and patent hemostasis can help to minimize radial artery risks, such as radial artery occlusion (RAO).2
Read more

Reference

 
  1. Kiemeneij F, et al, Catheter Cardiovasc Interv. 2003; 59 (2): 161-164
  2. Rathore S. et al., 2010. A Randomized Comparison of TR Band and Radistop Hemostatic Compression Devices Afer Trans-radial Coronary Intervention. Catheterization and Cardiovascular Interventions, 76 (5), pp.660–667.
How can we assist you?

At Terumo Interventional Systems, we don’t just deliver quality medical products – we offer the necessary resources and support to help you use them to their full potential. Contact us today for any assistance you may need.

Contact Us
Pattern (image)
Terumo Interventional Systems
 
Top
  • Products
    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Procedures
      • Access
      • TLA - Therapeutic Lesion Access
      • Imaging
      • Therapeutic
      • Closure
    • Categories
    • All Products
  • Featured Topics
    • Radial First
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Ultimaster
    • TLA - Therapeutic Lesion Access
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us
    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
    • Our Brand Story
  • News & Events
    • News
    • Events
 Newsletter
 
  1. Home
  2. Featured Topics
  3. Radial First
  4. TRI - Transradial Intervention
  5. TRI 30th
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Cookie Policy
  • Social Media Policy
  • Site Map
  • Contact Us

All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.